查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018771

长读长定序市场：按产品/服务、技术、应用和最终用户分類的全球市场预测，2026-2032年

Long Read Sequencing Market by Product & Service, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，长读定序市场价值将达到 10.9 亿美元，到 2026 年将成长到 14 亿美元，到 2032 年将达到 58.2 亿美元，年复合成长率为 26.92%。

主要市场统计数据
基准年 2025 10.9亿美元
预计年份：2026年 14亿美元
预测年份 2032 58.2亿美元
复合年增长率 (%) 26.92%

这篇简洁而权威的介绍说明了长读定序如何发展成为一个策略平台，重塑了研究、诊断和应用基因组学。

长读长定定序已从一项专门的研究技术发展成为一个策略平台，重塑了基因组研究、临床转化流程和应用生命科学。这项技术能够阐明复杂的基因组区域，确定长单倍型中等位基因的相位，并检测天然分子中的结构变异和表观遗传标记，从而开闢了短读长测序方法无法充分应用的领域。因此，研究机构、诊断实验室和产业应用者正在重新思考他们的技术架构、工作流程和供应商关係，以最大限度地发挥长读长定序的科学和营运优势。

从技术、商业性和工作流程变革的角度展望未来，这些变革正在重新定义整个产业中长读定定序的采用和营运模式。

长读长定序领域正经历一场变革，其驱动力包括技术的成熟、工作流程的整合以及终端使用者需求的不断变化。硬体和化学技术的进步提高了逐读测序的准确性和运行稳定性。模组化的仪器架构实现了可扩展的通量，从桌上型部署到高容量中心均可适用。同时，即时碱基编码和天然表观遗传检测技术的出现，催生了新的应用场景，在这些场景中，快速週转和多层次的分子资讯至关重要。

对美国到 2025 年的累积关税措施如何重塑定序系统中的筹资策略、供应韧性和供应商应对措施进行了深入分析。

美国计划在2025年前实施累积关税措施，这给整个长读长定序系统的采购、供应链韧性和筹资策略带来了新的挑战。进口设备和关键试剂关税的提高迫使各机构重新评估供应商关係和前置作业时间风险。为此，许多相关人员正在优先考虑供应商多元化，确保流动池和专用试剂盒等关键耗材的缓衝库存，并审查服务合约以确保价格和交货时间的合理性。

对产品、技术、应用和最终用户等各个维度上的细微细分趋势进行详细分析，为策略优先排序提供指南。

细分市场层面的趋势揭示了每种产品/服务、技术、应用和最终用户群体的不同驱动因素，而这些差异对于策略定位至关重要。在产品和服务细分中，来自流动池、试剂盒和试剂等耗材的持续收入仍然是营运的核心考虑因素，因为耗材的可靠性和连续性直接影响通量和实验可重复性。对定序系统及相关配件的投资决定了资本规划週期，而生物资讯服务、数据分析软体和维护服务则决定了长期营运支援和合规准备。

从区域比较情报的观点出发，分析全球主要区域的采用驱动因素、法律规范和商业生态系统的差异。

区域趋势反映了研究基础设施、法规环境和商业生态系统的差异，从而以不同的方式塑造了技术应用路径和竞争重点。在美洲，强大的学术研究网络、高度集中的临床试验活动以及成熟的供应商基础正在加速高精度长读长定序技术在肿瘤学、神经基因组学和微生物监测领域的应用。该地区还拥有成熟的公私合营模式，将定序整合到公共卫生倡议和转化项目中。

对企业发展趋势进行策略性回顾，展示平台创新、整合服务和不断演进的经营模式如何创造竞争优势。

长读长定序领域的企业策略正朝着几个通用的主题发展：提昇平台效能、管理耗材生命週期、整合软体和服务以及促进合作伙伴关係。领先的仪器供应商正投资于化学创新和孔径设计，以降低误差率并提高通量，同时也在扩展仪器外形规格，以适应更广泛的实验室安装空间。除了硬体的进步，各公司还在加速开发分析套件和託管服务，以消除临床和工业用户在需要检验的端到端工作流程时遇到的障碍。

为平衡供应链韧性、生物资讯投资、与监管机构合作以及以客户为中心的经营模式，提出切实可行的建议。

产业领导者应采取组合策略，兼顾短期业务永续营运和长期策略差异化。首先，应透过建立关键耗材（例如流动池和特种试剂）的多源采购策略来增强供应链韧性，并在适当情况下签订多年期合同，同时评估区域分销和组装方案，以减轻跨境关税波动的影响。其次，应优先投资于生物资讯学和数据管理。标准化、检验的流程和健全的资料管治能够加速临床部署并支援机构间合作。

对用于整合与技术趋势、相关人员观点和市场区隔一致的见解的实证分析过程进行透明的解释。

本执行摘要的研究结合了结构化的二手资料分析、专家访谈和多来源检验，以确保其严谨性和相关性。二手资料分析包括对同行评审文献、专利趋势、已发布的产品公告、监管文件和技术白皮书的系统性回顾，揭示了技术发展轨迹和创新热点。这些资讯来源被整合起来，用于识别新兴的绩效基准、工作流程转变和经营模式创新。

摘要阐明了为最大限度地发挥长读定序创新价值所必需的策略挑战和营运重点。

长读长定序正处于一个转折点，技术进步、应用拓展和商业实践的演进正在为研究机构、临床检查室和商业生命科学组织创造持久的策略价值。长读长定序能够提供长程基因组资讯、原生检测表观遗传标记并揭示结构复杂性，进而推动肿瘤学、微生物监测、农业育种和转化研究等领域的进步。结合对检验的分析方法和稳健供应链的投资，这些技术优势将转化为实际的营运和策略效益。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：长读长定序市场：依产品和服务划分

  • 消耗品
    • 流动池
    • 成套工具
    • 试剂
  • 装置
    • 配件
    • 定序系统
  • 软体服务
    • 生物资讯服务
    • 数据分析软体
    • 维护服务

第九章：长读长定序市场：依技术划分

  • 奈米孔定序
  • 单分子即时定序
  • 合成长读定序

第十章：长读长定序市场：依应用领域划分

  • 农业基因组学
  • 癌症基因体学
  • 临床研究
  • 微生物基因体学

第十一章：长读长定序市场：依最终用户划分

  • 学术机构
  • 临床诊断检查室
  • 合约研究机构
  • 政府和监管机构
  • 製药和生物技术

第十二章：长读长定序市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：长读长定序市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：长读长定序市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国长读长定序市场

第十六章：中国长读长定序市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arima Genomics, Inc.
  • BGI Genomics Co., Ltd.
  • Dovetail Genomics, LLC
  • Element Biosciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genapsys, Inc.
  • Hitachi High-Technologies Corporation
  • Illumina, Inc.
  • Nabsys, Inc.
  • Nuclera Nucleics Ltd.
  • Oxford Nanopore Technologies Limited
  • Pacific Biosciences of California, Inc.
  • Phase Genomics, Inc.
  • QIAGEN NV
  • Quantapore, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-A26E0E574570

The Long Read Sequencing Market was valued at USD 1.09 billion in 2025 and is projected to grow to USD 1.40 billion in 2026, with a CAGR of 26.92%, reaching USD 5.82 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.09 billion
Estimated Year [2026] USD 1.40 billion
Forecast Year [2032] USD 5.82 billion
CAGR (%) 26.92%

A concise and authoritative introduction explaining how long read sequencing has evolved into a strategic platform reshaping research, diagnostics, and applied genomics

Long read sequencing has moved from a specialized research capability into a strategic platform that is reshaping genomics research, clinical translational pipelines, and applied life sciences. The technology's ability to resolve complex genomic regions, phase alleles across long haplotypes, and detect structural variants and epigenetic marks in native molecules has unlocked applications that short-read methods cannot reliably address. As a result, research institutions, diagnostic labs, and industry adopters are re-evaluating technology stacks, workflows, and vendor relationships to capture the scientific and operational advantages offered by long reads.

In parallel, advances in chemistry, pore engineering, instrument design, and bioinformatics have increased read accuracy and throughput while simplifying sample preparation. These technical improvements, together with greater accessibility of analysis tools and cloud-enabled workflows, have lowered barriers to entry and broadened the user base beyond specialist sequencing centers. Consequently, organizations are moving from proof-of-concept studies to routine incorporation of long reads within programs in oncology, pathogen surveillance, crop improvement, and precision medicine.

Transitioning from experimental use to production-grade operations requires attention to reproducibility, regulatory readiness, and supply continuity. Institutions seeking to capitalize on long-read capability must therefore integrate robust data management, validation practices, and vendor-agnostic quality controls to ensure that the scientific gains translate into operational impact and credible clinical or regulatory outputs.

A forward-looking exploration of the technological, commercial, and workflow shifts that are redefining long read sequencing adoption and operational models across sectors

The landscape of long read sequencing is undergoing transformative shifts driven by technological maturation, workflow integration, and evolving end-user expectations. Hardware and chemistry advances have improved per-read accuracy and extended run stability, while modular instrument architectures permit scalable throughput from benchtop deployments to high-capacity centers. At the same time, real-time basecalling and native epigenetic detection have enabled new use cases where rapid turnaround and multi-layered molecular information are essential.

Concurrently, software ecosystems have shifted from bespoke academic scripts to enterprise-grade solutions that emphasize reproducibility, reproducible pipelines, and regulatory compliance. Cloud-native analysis frameworks, containerization, and standardized APIs are enabling cross-platform interoperability and easing barriers for clinical laboratories and CROs to adopt long-read workflows. Moreover, the commoditization of consumables and focus on sustainability in reagent manufacturing are influencing procurement strategies and long-term operating costs.

These changes are also manifesting in market behavior: vendors are diversifying commercial models to include instrument-as-a-service, subscription-based consumable plans, and integrated service offerings that bundle sequencing with bioinformatics and maintenance. As organizations reconsider long-term investments, attention is shifting toward total cost of ownership, lifecycle support, and the ability of technology partners to deliver validated workflows that meet regulatory and clinical-grade requirements.

An incisive assessment of how cumulative U.S. tariff measures through 2025 have reshaped procurement strategies, supply resilience, and vendor responses in the sequencing ecosystem

The cumulative tariff measures introduced in the United States through 2025 have introduced new dimensions to procurement, supply chain resilience, and sourcing strategies across the long read sequencing ecosystem. Increased duties on imported instruments and key reagents have prompted organizations to reassess vendor relationships and inventory policies to mitigate cost volatility and lead-time risk. In response, many stakeholders have prioritized diversification of suppliers, established buffer inventories for critical consumables like flow cells and specialized kits, and re-evaluated service contracts to lock in pricing and delivery windows.

Manufacturers and distributors have adapted by exploring onshore assembly, regional distribution centers, and partnerships with local manufacturers to reduce exposure to cross-border tariff impacts. For customers, the tariff environment has made lifecycle planning more complex: procurement cycles are extending as purchasers perform more thorough total-cost analyses and seek multi-year service agreements to manage post-tariff operating budgets. At the same time, some vendors have absorbed a portion of increased costs through pricing strategies that preserve installed-base loyalty, while others have accelerated investments in regional manufacturing to regain competitive positioning and shorten supply lines.

Overall, tariffs have emphasized the strategic value of supply-chain transparency, contractual flexibilities, and scenario planning. Organizations that proactively model tariff exposures, negotiate flexible terms, and develop alternative sourcing strategies are better positioned to sustain research continuity, protect clinical workflows, and maintain competitive timelines for product development and discovery.

A deep-dive synthesis of nuanced segmentation dynamics across product, technology, application, and end-user dimensions that inform strategic prioritization

Segment-level dynamics reveal differentiated drivers across products and services, technologies, applications, and end-user groups, and these distinctions are critical for strategic positioning. Within product and service segmentation, recurring revenue from consumables-including flow cells, kits, and reagents-remains a central operational consideration because consumable reliability and supply continuity directly affect throughput and experimental reproducibility. Investments in sequencing systems and supporting accessories shape capital planning cycles, whereas bioinformatics services, data analysis software, and maintenance services determine long-term operational support and regulatory readiness.

Across technology segmentation, nanopore sequencing has matured as a highly portable, real-time solution suited to field deployments and rapid surveillance, while single molecule real time sequencing has strengthened its niche where high per-read accuracy and circular consensus approaches are essential. Synthetic long read strategies continue to provide cost-effective alternatives for certain assembly tasks and large-genome projects where reconstructing long-range information from linked reads remains advantageous.

In terms of application, agricultural genomics benefits from long reads for structural variant detection and complex trait mapping, cancer genomics uses long-range phasing to resolve tumor heterogeneity, clinical research leverages comprehensive variant calling for translational studies, and microbial genomics relies on long reads for plasmid resolution and outbreak tracing. End users differ in priorities: academic centers focus on methodological innovation and novel use cases, clinical diagnostic laboratories emphasize validation, throughput, and compliance, contract research organizations offer turnkey sequencing services for multiple clients, government and regulatory bodies concentrate on surveillance and standardization, and pharmaceutical and biotechnology firms integrate long reads into target discovery and biomarker validation workflows.

A comparative regional intelligence perspective capturing how adoption drivers, regulatory frameworks, and commercial ecosystems diverge across major global regions

Regional dynamics are shaping adoption pathways and competitive priorities in distinct ways, reflecting differences in research infrastructure, regulatory environments, and commercial ecosystems. In the Americas, strong academic research networks, a dense concentration of clinical trial activity, and established vendor bases have accelerated adoption of high-accuracy long-read pipelines for oncology, neurogenomics, and microbial surveillance. This region also demonstrates mature public-private collaboration models that integrate sequencing into public health initiatives and translational programs.

In Europe, the Middle East & Africa, regulatory harmonization efforts and pan-European consortia are driving coordinated investments in reference genomes, surveillance networks, and cross-border data sharing. Research funding models in this region often emphasize collaborative infrastructure and standardized protocols, which in turn influence procurement cycles and demand for validated workflows and compliance-ready software. The presence of multiple language markets and diverse healthcare systems increases the importance of localized support and multi-jurisdictional regulatory expertise.

In the Asia-Pacific region, rapid capital deployment, expanding domestic manufacturing capabilities, and intensive activity in agricultural genomics and infectious disease surveillance have accelerated both adoption and innovation. Regional players often prioritize scalable platforms that balance throughput with cost-efficiency, and cross-border collaborations within the region are fostering ecosystem growth. Together, these regional distinctions inform go-to-market approaches, partnership models, and where to focus investments in local support and supply-chain resilience.

A strategic review of corporate behaviors showing how platform innovation, integrated services, and commercial model evolution are shaping competitive advantage

Corporate strategies within the long read sequencing domain are converging around several consistent themes: platform performance improvements, consumable lifecycle management, software and service integration, and collaborative partnerships. Leading instrument vendors are investing in chemistry innovations and pore design to reduce error profiles and improve throughput while expanding instrument form factors to address a broader range of laboratory footprints. Complementary to hardware advances, companies are accelerating development of analysis suites and managed services to remove barriers for clinical and industrial users who require validated, end-to-end workflows.

At the same time, commercial models are becoming more flexible. Subscription-based access to instruments, reagent bundling, and comprehensive support packages are emerging as viable alternatives to traditional capital purchase models. Strategic partnerships-spanning reagent manufacturers, cloud analytics providers, and academic consortia-are being used to extend addressable markets and accelerate application-specific validation, for example in oncology panels, crop genomics pipelines, and pathogen surveillance protocols. Service providers and CROs are expanding capabilities to include long-read-specific offerings, enabling customers to outsource sequencing and analysis while preserving data governance and quality.

Finally, companies are prioritizing supply-chain diversification and regional manufacturing to mitigate tariff exposure and logistics risk. Those that combine robust R&D roadmaps with transparent service level agreements and localized support infrastructures are increasingly attractive to large institutional buyers and enterprise customers seeking long-term partnerships.

Practical and actionable recommendations that balance supply resilience, bioinformatics investment, regulatory engagement, and customer-centric commercial models

Industry leaders should pursue a portfolio approach that balances near-term operational continuity with long-term strategic differentiation. First, strengthen supply-chain resilience by establishing multi-sourcing strategies for critical consumables such as flow cells and specialized reagents, negotiating multi-year commitments where appropriate, and evaluating regional distribution or assembly options to reduce exposure to cross-border tariff volatility. Second, prioritize investments in bioinformatics and data management: standardized, validated pipelines and robust data governance accelerate clinical adoption and support cross-institutional collaborations.

Third, align product and commercial models with distinct end-user needs by offering flexible procurement options for academic laboratories, validated turnkey solutions for clinical diagnostic customers, and scalable service packages for contract research organizations. Fourth, engage proactively with regulatory stakeholders and participate in standards-setting initiatives to ensure that new workflows meet evolving compliance expectations and to reduce time-to-validation for clinical applications. Fifth, invest in training and field support to lower adoption friction; hands-on education for laboratory staff and translational scientists will increase throughput and reduce error rates.

Taken together, these actions will enable organizations to capitalize on scientific advantages, secure operational continuity, and convert technical leadership into measurable outcomes for research programs, clinical services, and product development pipelines.

A transparent explanation of the evidence base and analytic processes used to synthesize technical trends, stakeholder perspectives, and segmentation-aligned insights

The research underpinning this executive summary combines structured secondary analysis, expert interviews, and cross-source validation to ensure rigor and relevance. Secondary analysis included a systematic review of peer-reviewed literature, patent activity, public product announcements, regulatory filings, and technical white papers to map technology trajectories and innovation hotspots. These sources were synthesized to identify emerging performance benchmarks, workflow shifts, and commercial model innovations.

Complementing the literature review, qualitative interviews were conducted with laboratory directors, technology adopters, procurement leads, and industry strategists to ground technical trends in operational realities and procurement constraints. Interview insights informed interpretations of vendor strategies, customer pain points, and the practical implications of tariff-driven supply-chain changes. Findings were triangulated across sources to reduce bias and confirm recurring themes.

Finally, segmentation frameworks were applied to align insights with product categories, technology types, application domains, and end-user profiles. Limitations include the evolving nature of instrument performance claims and potential lag in public disclosures for proprietary developments; accordingly, the methodology emphasizes transparency about assumptions and recommends follow-up validation for investment decisions or procurement commitments.

A concluding synthesis that clarifies the strategic imperatives and operational priorities required to capture the full value of long read sequencing innovations

Long read sequencing stands at an inflection point where technical progress, expanding application breadth, and evolving commercial practices are creating sustained strategic value for research institutions, clinical laboratories, and commercial life-science organizations. The capacity to deliver long-range genomic information, detect epigenetic marks natively, and resolve structural complexity is catalyzing advancements in oncology, microbial surveillance, agricultural breeding, and translational research. When combined with investments in validated analytics and resilient supply chains, these technical strengths translate into tangible operational and strategic benefits.

However, realizing this potential requires deliberate actions: prioritizing validated workflows for regulated settings, building redundancies in consumable sourcing, and investing in software and services that ensure reproducibility and regulatory compliance. Stakeholders that align procurement, R&D planning, and partnership strategies with these imperatives will be best positioned to extract sustained value. In contrast, organizations that delay integration of long-read data into their pipelines risk falling behind in capabilities that increasingly define competitive research and clinical programs.

Ultimately, the trajectory of long read sequencing will continue to be shaped by innovations in chemistry and informatics, by the adaptability of commercial models, and by the ability of users and vendors to collaborate on standards, validation, and training that underpin broad, reliable adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Long Read Sequencing Market, by Product & Service

  • 8.1. Consumables
    • 8.1.1. Flow Cells
    • 8.1.2. Kits
    • 8.1.3. Reagents
  • 8.2. Instruments
    • 8.2.1. Accessories
    • 8.2.2. Sequencing Systems
  • 8.3. Software & Services
    • 8.3.1. Bioinformatics Services
    • 8.3.2. Data Analysis Software
    • 8.3.3. Maintenance Services

9. Long Read Sequencing Market, by Technology

  • 9.1. Nanopore Sequencing
  • 9.2. Single Molecule Real Time Sequencing
  • 9.3. Synthetic Long Read Sequencing

10. Long Read Sequencing Market, by Application

  • 10.1. Agricultural Genomics
  • 10.2. Cancer Genomics
  • 10.3. Clinical Research
  • 10.4. Microbial Genomics

11. Long Read Sequencing Market, by End User

  • 11.1. Academic
  • 11.2. Clinical Diagnostic Laboratories
  • 11.3. Contract Research Organizations
  • 11.4. Government And Regulatory Bodies
  • 11.5. Pharmaceutical And Biotechnology

12. Long Read Sequencing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Long Read Sequencing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Long Read Sequencing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Long Read Sequencing Market

16. China Long Read Sequencing Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arima Genomics, Inc.
  • 17.6. BGI Genomics Co., Ltd.
  • 17.7. Dovetail Genomics, LLC
  • 17.8. Element Biosciences, Inc.
  • 17.9. F. Hoffmann-La Roche Ltd.
  • 17.10. Genapsys, Inc.
  • 17.11. Hitachi High-Technologies Corporation
  • 17.12. Illumina, Inc.
  • 17.13. Nabsys, Inc.
  • 17.14. Nuclera Nucleics Ltd.
  • 17.15. Oxford Nanopore Technologies Limited
  • 17.16. Pacific Biosciences of California, Inc.
  • 17.17. Phase Genomics, Inc.
  • 17.18. QIAGEN N.V.
  • 17.19. Quantapore, Inc.
  • 17.20. Takara Bio Inc.
  • 17.21. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LONG READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LONG READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 155. GCC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 156. GCC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 157. GCC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. GCC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 179. G7 LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 180. G7 LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 181. G7 LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. G7 LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. G7 LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 187. NATO LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 188. NATO LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 189. NATO LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. NATO LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)